Citigroup downgraded shares of Sherwin-Williams (NYSE:SHW - Free Report) from a buy rating to a neutral rating in a research report report published on Friday, MarketBeat reports. The brokerage currently has $385.00 price objective on the specialty chemicals company's stock, down from their prior price objective of $405.00.
A number of other equities analysts have also weighed in on SHW. Royal Bank of Canada upped their price objective on Sherwin-Williams from $410.00 to $420.00 and gave the stock an "outperform" rating in a research note on Thursday, May 1st. Morgan Stanley dropped their price target on Sherwin-Williams from $405.00 to $385.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Jefferies Financial Group reiterated a "hold" rating and set a $380.00 price objective (down previously from $423.00) on shares of Sherwin-Williams in a research report on Monday, March 10th. Mizuho set a $395.00 target price on shares of Sherwin-Williams in a research report on Tuesday, April 15th. Finally, UBS Group cut their target price on shares of Sherwin-Williams from $430.00 to $400.00 and set a "buy" rating for the company in a research note on Monday, April 7th. Six investment analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, Sherwin-Williams presently has a consensus rating of "Moderate Buy" and a consensus price target of $397.67.
Get Our Latest Report on Sherwin-Williams
Sherwin-Williams Stock Performance
Shares of Sherwin-Williams stock traded down $20.27 on Friday, hitting $335.93. 2,793,639 shares of the company's stock were exchanged, compared to its average volume of 1,722,765. Sherwin-Williams has a 1 year low of $292.27 and a 1 year high of $400.42. The company has a 50-day simple moving average of $347.71 and a 200-day simple moving average of $352.35. The company has a debt-to-equity ratio of 2.02, a quick ratio of 0.46 and a current ratio of 0.79. The stock has a market capitalization of $84.18 billion, a PE ratio of 31.84, a PEG ratio of 2.98 and a beta of 1.21.
Sherwin-Williams (NYSE:SHW - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The specialty chemicals company reported $2.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.23 by $0.02. Sherwin-Williams had a return on equity of 74.50% and a net margin of 11.61%. The business had revenue of $5.31 billion during the quarter, compared to analyst estimates of $5.42 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. Sherwin-Williams's revenue for the quarter was down 1.1% on a year-over-year basis. As a group, equities analysts anticipate that Sherwin-Williams will post 12 EPS for the current year.
Sherwin-Williams Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 6th. Shareholders of record on Friday, May 16th were given a dividend of $0.79 per share. This represents a $3.16 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date of this dividend was Friday, May 16th. Sherwin-Williams's dividend payout ratio (DPR) is 29.87%.
Institutional Investors Weigh In On Sherwin-Williams
Several institutional investors have recently made changes to their positions in SHW. Vanguard Group Inc. lifted its stake in Sherwin-Williams by 1.1% in the first quarter. Vanguard Group Inc. now owns 22,082,544 shares of the specialty chemicals company's stock worth $7,711,004,000 after purchasing an additional 245,896 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Sherwin-Williams by 21.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 8,657,536 shares of the specialty chemicals company's stock worth $3,023,126,000 after buying an additional 1,505,341 shares during the period. FMR LLC lifted its stake in shares of Sherwin-Williams by 1.6% during the 4th quarter. FMR LLC now owns 6,588,755 shares of the specialty chemicals company's stock worth $2,239,715,000 after acquiring an additional 106,093 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Sherwin-Williams by 2.0% during the 4th quarter. Geode Capital Management LLC now owns 4,829,702 shares of the specialty chemicals company's stock valued at $1,636,679,000 after acquiring an additional 96,571 shares during the period. Finally, Alliancebernstein L.P. increased its stake in Sherwin-Williams by 2.2% in the first quarter. Alliancebernstein L.P. now owns 4,409,209 shares of the specialty chemicals company's stock worth $1,539,652,000 after purchasing an additional 93,209 shares during the period. Institutional investors own 77.67% of the company's stock.
Sherwin-Williams Company Profile
(
Get Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Further Reading

Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.